BioLargo Director Christina Bray Receives 165,198 Stock Options for Board Service Fees

BioLargo, Inc. director Christina Bray received 165,198 stock options on June 30, 2026, as compensation for $18,750 in board service fees for the most recently completed quarterly period. The options were issued under the company's 2024 Equity Incentive Plan with an exercise price of $0.1135 per share and an expiration date of June 30, 2036. Following this transaction, Bray now holds 1,546,700 options. The filing includes a limited power of attorney document dated November 1, 2022, authorizing John R. Browning to file Section 16 reports on Bray's behalf. This transaction represents non-cash compensation to a director for board services rendered to the company.